Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides

Brad A. Hartl; David L. Boucher; Laura Marcu; Simon R Cherry

Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides

Brad A. Hartl, David L. Boucher, Laura Marcu, Simon R Cherry

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Abstract

Cerenkov luminescence generated from radionuclides was used as a novel light source for photodynamic therapy. This technique, in conjunction with administration of δ-aminolevulinic acid, was shown to inhibit growth of U-87 glioblastoma cells in vitro.

Original language	English (US)
Title of host publication	Optical Trapping Applications, OTA 2013
State	Published - 2013
Event	Optical Trapping Applications, OTA 2013 - Waikoloa Beach, HI, United States Duration: Apr 14 2013 → Apr 18 2013

Other

Other	Optical Trapping Applications, OTA 2013
Country	United States
City	Waikoloa Beach, HI
Period	4/14/13 → 4/18/13

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Atomic and Molecular Physics, and Optics

Fingerprint Dive into the research topics of 'Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides'. Together they form a unique fingerprint.

Cite this

@inproceedings{b37d1a6b3000428dbd4d11e2fdd474ef,

title = "Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides",

abstract = "Cerenkov luminescence generated from radionuclides was used as a novel light source for photodynamic therapy. This technique, in conjunction with administration of δ-aminolevulinic acid, was shown to inhibit growth of U-87 glioblastoma cells in vitro.",

author = "Hartl, {Brad A.} and Boucher, {David L.} and Laura Marcu and Cherry, {Simon R}",

year = "2013",

language = "English (US)",

isbn = "9781557529664",

booktitle = "Optical Trapping Applications, OTA 2013",

note = "Optical Trapping Applications, OTA 2013 ; Conference date: 14-04-2013 Through 18-04-2013",

}

TY - GEN

T1 - Photodynamic therapy activated with cerenkov luminescence from beta-emitting radionuclides

AU - Hartl, Brad A.

AU - Boucher, David L.

AU - Marcu, Laura

AU - Cherry, Simon R

PY - 2013

Y1 - 2013

N2 - Cerenkov luminescence generated from radionuclides was used as a novel light source for photodynamic therapy. This technique, in conjunction with administration of δ-aminolevulinic acid, was shown to inhibit growth of U-87 glioblastoma cells in vitro.

AB - Cerenkov luminescence generated from radionuclides was used as a novel light source for photodynamic therapy. This technique, in conjunction with administration of δ-aminolevulinic acid, was shown to inhibit growth of U-87 glioblastoma cells in vitro.

UR - http://www.scopus.com/inward/record.url?scp=84887672260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887672260&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:84887672260

SN - 9781557529664

BT - Optical Trapping Applications, OTA 2013

T2 - Optical Trapping Applications, OTA 2013

Y2 - 14 April 2013 through 18 April 2013

ER -